We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+308.35%
AUM
$6.43B
AUM Growth
-$341M
Cap. Flow
-$616M
Cap. Flow %
-9.59%
Top 10 Hldgs %
35.62%
Holding
105
New
5
Increased
7
Reduced
76
Closed
8

Sector Composition

Rank Sector Weight
1 Financials 28.72%
2 Communication Services 18.78%
3 Materials 13.17%
4 Energy 10.2%
5 Technology 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXC icon
76
DXC Technology
DXC
$1.73B
$7.54M 0.12%
422,657
-76,634
-15% -$1.4M
FLR icon
77
Fluor
FLR
$7.96B
$6.01M 0.09%
682,704
-225,175
-25% -$2.37M
FTS icon
78
Fortis
FTS
$28.7B
$3.88M 0.06%
95,100
-5,000
-5% -$200K
PDS
79
Precision Drilling
PDS
$974M
$3.63M 0.06%
291,721
-20,183
-6% -$273K
SJR
80
DELISTED
Shaw Communications Inc.
SJR
$2.46M 0.04%
135,475
INFY icon
81
Infosys
INFY
$50.7B
$2.34M 0.04%
169,325
-1,800
-1% -$22.5K
ING icon
82
ING
ING
$102B
$980K 0.02%
138,479
-4,286
-3% -$32.8K
REPL icon
83
Replimune Group
REPL
$1.01B
$976K 0.02%
+42,400
New +$966K
KOD icon
84
Kodiak Sciences
KOD
$2.84B
$872K 0.01%
14,725
-550
-4% -$27.6K
HRTX icon
85
Heron Therapeutics
HRTX
$92.9M
$848K 0.01%
57,200
+12,200
+27% +$190K
PROF
86
Profound Medical
PROF
$269M
$811K 0.01%
+46,000
New +$731K
MYOV
87
DELISTED
Myovant Sciences Ltd.
MYOV
$703K 0.01%
50,000
-1,500
-3% -$27.9K
UNH icon
88
UnitedHealth
UNH
$370B
$577K 0.01%
1,850
MET icon
89
MetLife
MET
$62.1B
$487K 0.01%
13,099
V icon
90
Visa
V
$677B
$456K 0.01%
2,280
TFII icon
91
TFI International
TFII
$11.5B
$390K 0.01%
9,367
MSFT icon
92
Microsoft
MSFT
$3.71T
$379K 0.01%
+1,800
New +$378K
AAPL icon
93
Apple
AAPL
$4.57T
$329K 0.01%
2,840
QNCX icon
94
Quince Therapeutics
QNCX
$29.5M
$309K ﹤0.01%
31
-7
-18% -$63.7K
BCEL
95
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$249K ﹤0.01%
+17,800
New +$265K
DUK icon
96
Duke Energy
DUK
$97.3B
$230K ﹤0.01%
+2,600
New +$214K
E icon
97
ENI
E
$77.5B
$202K ﹤0.01%
13,000
BB icon
98
BlackBerry
BB
$5.26B
-2,652,231
Closed -$12.9M
EFA icon
99
iShares MSCI EAFE ETF
EFA
$80.2B
-7,275
Closed -$443K
IWB icon
100
iShares Russell 1000 ETF
IWB
$50.2B
-1,709
Closed -$293K

Similar funds

Letko, Brosseau & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Letko, Brosseau & Associates held 105 positions worth $6.43B, down 5% from $6.77B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Letko, Brosseau & Associates withdrew a net $616M in Q3 2020, closing 8 positions and reducing 76 holdings. Its most notable exit was BlackBerry, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Letko, Brosseau & Associates opened a new position in Replimune Group worth $976K.

  • Letko, Brosseau & Associates's largest Q3 2020 buy was Replimune Group: 42,400 shares worth $976K.
  • Letko, Brosseau & Associates added most to CAE Inc. Common Shares in Q3 2020, an estimated $28.5M increase.
  • Letko, Brosseau & Associates's biggest Q3 2020 reduction was Brookfield Property Partners L.P. Limited Partnership Units, cutting an estimated $36.3M.
  • Letko, Brosseau & Associates fully exited BlackBerry in Q3 2020, selling an estimated $12.9M.
  • Letko, Brosseau & Associates's ten largest holdings make up 36% of its $6.43B portfolio in Q3 2020.
  • Letko, Brosseau & Associates opened 5 new positions and closed 8 in Q3 2020.
  • Letko, Brosseau & Associates's portfolio value fell 5% quarter-over-quarter to $6.43B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2020, filed 9 Nov 2020.